MD Anderson accelerates cellular therapy programs by buying...
Cellular therapies have emerged as an effective new therapy for patients with certain types of cancer, and MD Anderson has played an...
International consortium publishes recommendations for...
An international consortium, led in part by clinicians and researchers from The University of Texas MD Anderson Cancer Center, has...
Study shows early-onset colorectal cancers have distinct...
Through in-depth retrospective analysis of data from more than 36,000 patients, a new study led by researchers at The University of...
Pancreatic Cancer Moon Shot sharpens pre-surgical treatment
Neoadjuvant therapy is treatment, such as chemotherapy or radiation, given before a patient has surgery. This approach is used in many...
The search for valuable cancer-related proteins
MD Anderson’s proteomics platform provides a valuable institutional resource, complete with state-of-the-art instruments and...
Treatment advances for CLL, the most common leukemia
Chronic lymphocytic leukemia (CLL), which originates in white blood cells known as lymphocytes, is the most common form of leukemia in...
$5.1 million grant to expand cervical cancer diagnosis and...
MD Anderson Cancer Center researchers, together with collaborators from Mozambique, Brazil and the U.S., have been awarded a $5.1...
Expressive writing improves quality of life for breast...
Receiving a cancer diagnosis is a life-changing event, and the path through treatment can be among the hardest things a person goes...
Improving B-cell lymphoma treatment with immunotherapies...
Lymphomas are the most common hematological malignancy in the U.S., accounting for an estimated 80,000 new cancer diagnoses and 21,000...
Be Well Baytown celebrates one year of making impact on...
It is estimated that up to half of all cancers may be prevented by making healthy lifestyle choices. Cancer prevention and control is...